25 research outputs found
ANTIPROLIFERATIVE AND APOPTOTIC EFFECTS OF PONATINIB AND ITS EFFECTS ON MACROMOLECULAR CHANGES IN IMATINIB-SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA (CML) CELL LINES: A MECHANISTIC APPROACH
20th Congress of European-Hematology-Association[No abstract available
EXPRESSION LEVELS OF CERAMIDE-METABOLISING GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: THE DISCOVERY OF NOVEL TARGETS IN CML
5th International Eurasian Hematology Congress -- OCT 15-19, 2014 -- Antalya, TURKEYWOS: 00034724420011
EXPRESSION LEVELS OF CERAMIDE-GENERATING AND CLEARANCE GENES IN NEWLY DIAGNOSED AND TYROSINE KINASE INHIBITOR-RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS: AN ATTEMPT TO FIND NOVEL TARGETS
19th Congress of the European-Hematology-Association -- JUN 12-15, 2014 -- Milan, ITALYWOS: 000342830900170European Hematol Asso
DISCOVERING ALTERNATIVE TARGETS IN CHRONIC MYELOID LEUKEMIA (CML): DETERMINATION OF EXPRESSION LEVELS OF BIOACTIVE SPHINGOLIPID GENES IN NEWLY DIAGNOSED AND DRUG-RESISTANT CML PATIENTS
20th Congress of European-Hematology-Association -- JUN 11-14, 2015 -- Vienna, AUSTRIAWOS: 00036120490307
JAK/STAT SIGNALING PATHWAY GENES IN THE REGULATION OF TYROSINE KINASE INHIBITORS INDUCED AND CLINICAL PROCESS IN CHRONIC MYELOID LEUKEMIA PATIENTS
5th International Eurasian Hematology Congress -- OCT 15-19, 2014 -- Antalya, TURKEYWOS: 00034724420009
A NOVEL BIOMARKER FOR DRUG RESISTANCE IN CHRONIC MYELOID LEUKEMIA: MICRORNA-17
5th International Eurasian Hematology Congress -- OCT 15-19, 2014 -- Antalya, TURKEYWOS: 00034724420011